Millipore - Millipore Receives Prestigious Frost & Sullivan Innovation Award

Millipore Receives Prestigious
Frost & Sullivan Innovation Award

Billerica, Massachusetts—December 6, 2007— Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, today was awarded the 2007 Frost & Sullivan Technology Innovation of the Year Award in the U.S. Drug Discovery Technologies market.

This prestigious Award recognizes Millipore's UCOE(TM) technology (Ubiquitous Chromatin Opening Element) which offers significant benefits to manufacturers of biologic-based medicines. With its UCOE program, Millipore has introduced high expression elements that revolutionize the speed by which protein therapeutics can be produced in mammalian cells. UCOE technology aids isolation of highly productive clonal lines by screening nearly 100 clones in less than four months, which is 12 to 15 months faster than the gene amplification-based program of conventional technologies.

"We are immensely proud of the team responsible for developing the UCOE technology," said Millipore President and CEO Martin Madaus. "They demonstrate the high caliber of scientific knowledge and research skill that is the foundation of Millipore's success. We hope that receiving the Frost & Sullivan Technology Innovation Award will bring about expanded awareness of our dedication to bringing innovative new products and expertise to the Life Science Industry."

"Having established itself as a leader in separations methodologies, Millipore has successfully entered the growing market for protein expression products in the biopharmaceutical industry," notes Frost & Sullivan Industry Analyst Shankar Sellappan, Ph.D. "Millipore's innovative UCOE(TM) technology is expected to have a lasting impact on drug discovery efforts and on the development and manufacturing of therapeutic drugs."

Four members of Millipore's Bioprocess Division, Andrew Bulpin, Richard Malavarca, John Wynne and Wayne Vaz, accepted the Frost & Sullivan Award on December 5 at the 2007 Excellence in Healthcare Opportunities Awards Banquet in Orlando, FL.

"We could not have achieved this Award without the dedication and foresight of our senior management," said Andrew Bulpin, Vice President of Upstream Processing in the Bioprocess Division. "The UCOE program required a substantial commitment from Millipore to expand our technological base. That commitment not only benefits Millipore, but also our customers and the patients who receive life-saving drugs developed using UCOE technology."

Each year Frost & Sullivan presents the Technology Innovation of the Year Award to the company that has demonstrated technological superiority within its industry. This Award recognizes the ability of the company to successfully develop and introduce new technology and make significant product performance contributions to the industry.

About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees in 47 countries worldwide.

ADVANCING LIFE SCIENCE TOGETHER™
Research. Development. Production.

About Frost and Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.

Contacts:

Millipore Media Contact
Karen Marinella Hall, 978-715-1567
Director of Corporate Communications
or
Investor Relations Contact
Joshua Young, 978-715-1527
Director of Investor Relations

Sustainability

Our commitment to environmental stewardship.

» More

Find A Location

Find the Millipore office or expert closest to you.

Contact Us

We want to hear from you. Contact a specific department below or click "Suggestions and Feedback" to send your comments.